We are live on !
Find out more
AC
Apogem Capital Portfolio holdings
AUM
$303K
Turnover
99.25%
1-Year Est. Return
46.01%
This Fund
S&P 500
This Quarter Est. Return
-31.79%
1 Year Est. Return
-46.01%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$303K
AUM Growth
-$100M
(-100%)
Cap. Flow
-$99.3M
Cap. Flow % of AUM
Cap. Flow %
-32,796.08%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
133
New
–
Increased
–
Reduced
–
Closed
132
Avg Time Held
Equity + Options
1.3
years
Top 10 Avg Time Held
Equity + Options
0
years
Top 20 Avg Time Held
Equity + Options
0
years
Avg Time Held Equity only
1.3
years
Top 10 Avg Time Held Equity only
0
years
Top 20 Avg Time Held Equity only
0
years
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Orion
OEC
|
+$5.7M |
| 2 |
Zeta Global
ZETA
|
+$5.18M |
| 3 |
BlueLinx
BXC
|
+$4.46M |
| 4 |
Green Plains
GPRE
|
+$3.81M |
| 5 |
Dropbox
DBX
|
+$3.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 100% |
| 2 | Consumer Discretionary | 0% |
| 3 | Consumer Staples | 0% |
| 4 | Energy | 0% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
DELISTED
Accolade Inc
ACCD
| $303K | 100% |
38,883
| – | – |
2021 Q3
5 quarters
|
|
2
ACV Auctions
ACVA
| – | – |
-40,000
| Closed | -$288K | – |
|
3
ADC Therapeutics
ADCT
$184M
| – | – |
-17,405
| Closed | -$84K | – |
|
4
Aldeyra Therapeutics
ALDX
$40.1M
| – | – |
-85,091
| Closed | -$454K | – |
|
5
Alkermes
ALKS
$7.21B
| – | – |
-35,751
| Closed | -$798K | – |
|
6
Amazon
AMZN
$2.83T
| – | – |
-6,232
| Closed | -$704K | – |
|
7
Apollo Global Management
APO
$65.5B
| – | – |
-9,573
| Closed | -$445K | – |
|
8
Ardelyx
ARDX
$798M
| – | – |
-79,142
| Closed | -$94K | – |
|
9
Broadcom
AVGO
$1.6T
| – | – |
-15,940
| Closed | -$708K | – |
|
10
Dauch Corp
DCH
$1.13B
| – | – |
-29,426
| Closed | -$201K | – |
|
11
Alibaba
BABA
$270B
| – | – |
-6,500
| Closed | -$520K | – |
|
12
Blackbaud
BLKB
$2.42B
| – | – |
-19,628
| Closed | -$865K | – |
|
13
Backblaze
BLZE
$575M
| – | – |
-36,800
| Closed | -$183K | – |
|
14
Boston Scientific
BSX
$65.3B
| – | – |
-11,669
| Closed | -$452K | – |
|
15
Blackstone
BX
$85.5B
| – | – |
-3,511
| Closed | -$294K | – |
|
|
16
BlueLinx
BXC
$570M
| – | – |
-71,871
| Closed | -$4.46M | – |
|
17
Cadre Holdings
CDRE
$1.16B
| – | – |
-32,920
| Closed | -$792K | – |
|
18
DELISTED
Confluent
CFLT
| – | – |
-17,773
| Closed | -$422K | – |
|
19
Chefs' Warehouse
CHEF
$4.54B
| – | – |
-38,986
| Closed | -$1.13M | – |
|
20
Cigna
CI
$78.9B
| – | – |
-5,736
| Closed | -$1.59M | – |
|
21
Clarus
CLAR
$139M
| – | – |
-77,495
| Closed | -$1.04M | – |
|
22
Cannae Holdings
CNNE
$691M
| – | – |
-30,247
| Closed | -$625K | – |
|
23
Charles River Laboratories
CRL
$14.3B
| – | – |
-2,370
| Closed | -$466K | – |
|
24
Constellium
CSTM
$3.46B
| – | – |
-78,452
| Closed | -$796K | – |
|
25
Castle Biosciences
CSTL
$982M
| – | – |
-9,130
| Closed | -$238K | – |
|
Similar funds
IPCP
SHG
EC
RIR
FWM
SKCP
OP
OHU
Apogem Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Apogem Capital held 133 positions worth $303K, down 100% from $100M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Apogem Capital withdrew a net $99.3M in Q4 2022, closing 132 positions. Its most notable exit was Orion, an estimated $5.7M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 100% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
- Apogem Capital fully exited Orion in Q4 2022, selling an estimated $5.7M.
- Apogem Capital's ten largest holdings make up 100% of its $303K portfolio in Q4 2022.
- Apogem Capital opened 0 new positions and closed 132 in Q4 2022.
- Apogem Capital's portfolio value fell 100% quarter-over-quarter to $303K.
Based on Apogem Capital's 13F filing for Q4 2022, filed 13 Feb 2023.